EUVIMEDEUVIMED entdecken
Crossref

Oncogenic KRAS as an Architect of Mucinous Lineage Identity in Ovarian Carcinoma: Signaling Networks and Epithelial Reprogramming

I Putu Thio Mahapradana, Ni Putu Renata Mawardani, I Made Egga Adika Suputra, I Putu Eka Widiadnyana Putra, I Gede Putu Supadmanaba, I Nyoman Bayu Mahendra

Anatomy and Histology Journal of Indonesia · 08.12.2025 · 1 (2) · 41-50

DOI: 10.51559/40jby506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anatomy and Histology Journal of Indonesia, online erschienen am 08.12.2025. Verfasst von I Putu Thio Mahapradana und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary mucinous ovarian carcinoma (MOC) represents a unique biological entity that frequently exhibits resistance to standard chemotherapy. A major clinical challenge in MOC management remains accurately distinguishing primary tumors from gastrointestinal metastases. This narrative review synthesizes current evidence on how oncogenic KRAS signaling functions as a "master architect" driving lineage plasticity and shaping cellular identity in MOC. The literature indicates that KRAS/MAPK hyperactivation extends beyond driving cellular proliferation to orchestrate massive epithelial reprogramming. It actively recruits key transcription factors (such as AP-1, FOXA, and CDX2) that physically remodel chromatin and establish super-enhancers to epigenetically "lock in" a mucinous and intestinal identity. Furthermore, this state is continuously reinforced by a pro-inflammatory tumor microenvironment (via the IL-6/STAT3 axis) and specific metabolic adaptations, including enhanced glycolysis and glutaminolysis, creating a robust feed-forward loop. This mechanistic integration establishes that mucinous differentiation is not a static morphological label, but rather an actively maintained transcriptional state. Consequently, the clinical paradigm for MOC must shift toward precision oncology. This demands rigorous primary diagnostic confirmation intrinsically coupled with comprehensive molecular stratification. Future therapeutic strategies must move beyond conventional chemotherapy to exploit specific vulnerabilities within epigenetic circuits, metabolic dependencies, and targetable molecular subgroups (such as ERBB2 amplification), ultimately dismantling the resilient cellular identity of this recalcitrant tumor.

Zitieren

APA

Mahapradana, I. P. T., Mawardani, N. P. R., Suputra, I. M. E. A., Putra, I. P. E. W., Supadmanaba, I. G. P., & Mahendra, I. N. B. (2025). Oncogenic KRAS as an Architect of Mucinous Lineage Identity in Ovarian Carcinoma: Signaling Networks and Epithelial Reprogramming. Anatomy and Histology Journal of Indonesia, 1(2), 41-50. https://doi.org/10.51559/40jby506

Vancouver

Mahapradana IPT, Mawardani NPR, Suputra IMEA, Putra IPEW, Supadmanaba IGP, Mahendra INB. Oncogenic KRAS as an Architect of Mucinous Lineage Identity in Ovarian Carcinoma: Signaling Networks and Epithelial Reprogramming. Anatomy and Histology Journal of Indonesia. 2025;1(2):41-50. doi:10.51559/40jby506

BibTeX
@article{Mahapradana2025,
  author = {Mahapradana, I Putu Thio and Mawardani, Ni Putu Renata and Suputra, I Made Egga Adika and Putra, I Putu Eka Widiadnyana and Supadmanaba, I Gede Putu and Mahendra, I Nyoman Bayu},
  title = {Oncogenic KRAS as an Architect of Mucinous Lineage Identity in Ovarian Carcinoma: Signaling Networks and Epithelial Reprogramming},
  journal = {Anatomy and Histology Journal of Indonesia},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {41--50},
  doi = {10.51559/40jby506}
}
Kostenlos starten →